Polycystic ovary syndrome in Iranian adolescents

International Journal of Adolescent Medicine and Health

Volumn 26, Issue 4, 2014, Pages 559-565

  Esmaeilzadeh, Seddigheh ^a   Delavar, Mouloud Agajani ^a   Amiri, Mania ^a   Khafri, Soraya ^a   Pasha, Nargess Gholizadeh ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adolescent; Insulin resistance; Ovary syndrome

Indexed keywords

ACNE; ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH SCHOOL STUDENT; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; IRAN; IRANIAN PEOPLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; WITHDRAWAL BLEEDING; WRIST; BLOOD; MORPHOMETRICS; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; SOCIOECONOMICS; YOUNG ADULT;

GLUCOSE BLOOD LEVEL; LIPID; SEX HORMONE;

ADOLESCENT; BLOOD GLUCOSE; BODY WEIGHTS AND MEASURES; CROSS-SECTIONAL STUDIES; FEMALE; GONADAL STEROID HORMONES; HIRSUTISM; HUMANS; IRAN; LIPIDS; MENARCHE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84925227204     PISSN: 03340139     EISSN: 21910278     Source Type: Journal    
DOI: 10.1515/ijamh-2013-0335     Document Type: Article

References (35)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8.
2. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-51.
3. Freemark M. Management of adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:3354-6.
4. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-88.
5. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod2004;19:41-7.
6. Avvad CK, Holeuwerger R, Silva VC, Bordallo MA, Breitenbach MM. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 2001;15:170-7.
7. Rackow BW. Polycystic ovary syndrome in adolescents. Curr Opin Obstet Gynecol 2012;24:281-7.
8. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011;62:238-42.
9. Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, et al. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004;89:4331-7.
10. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
11. Ganie MA, Farooqui KJ, Bhat MA, Mir MM, Shah ZA, et al. Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome. Indian J Endocrinol Metab 2012;16:277-82.
12. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
13. Thiboutot D, Archer DF, Lemay A, Washenik K, Roberts J, et al. A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment. Fertil Steril 2001;76:461-8.
14. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 2000;320:1240-3.
15. Wamala SP, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K. Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women. Am J Public Health 1999;89:315-21.
16. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, et al. CDC growth charts: United States. Adv Data 2000;8:1-27.
17. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;1-190.
18. Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010;203:201e1-5.
19. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-14.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Beckman FN, Belisle C. Blood glucose self-monitoring. An evaluation of five systems. Consultant 1988;28:99-103, 6-7, 10 passim.
22. Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes 2010;15;1:36-47.
23. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;18;107:1448-53.
24. Delavar MA, Hajian-Tilaki KO. Age at menarche in girls born from 1985 to 1989 in Mazandaran, Islamic Republic of Iran. East Mediterr Health J. 2008;14:90-4.
25. Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan ST. Prevalence of metabolic syndrome among middle aged women in Babol, Iran. Southeast Asian J Trop Med Public Health 2009;40:612-28.
26. Esmaeilzadeh S, Delavar MA, Zeinalzadeh M, Mir MR. Epidemiology of infertility: a population-based study in Babol, Iran. Women Health 2012;52:744-54.
27. Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011;9:144.
28. Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, et al. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004;62:278-82.
29. Mitchell JA, Rodriguez D, Schmitz KH, Audrain-McGovern J. Sleep duration and adolescent obesity. Pediatrics 2013;131:e1428-34.
30. Nageswara Rao GS, Gurumurthy P, E S, Cherian KM. The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents. J Clin Diagn Res 2013;7:618-21.
31. Zalilah MS, Mirnalini K, Khor GL, Merlin A, Bahaman AS, et al. Estimates and distribution of body mass index in a sample of Malaysian adolescents. Med J Malaysia 2006;61:48-58.
32. Li M, Yan H, Dibley MJ, Chang SY, Sibbritt D. [Prevalence of overweight and obesity and its associated risk factors in students aged 11-17 in Xi'an in 2004]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006;28:234-9.
33. Wardle J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 2008;87:398-404.
34. Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J Obstet Gynaecol 2004;24:613-21.
35. Li L, Chen X, He Z, Zhao X, Huang L, et al. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol 2012;25:390-5.